Showing results (61-70 of 3,965) with videos related to

Sort By:
Pageof 397
Reviews of Infectious Diseases|July 1, 1988
Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDSD T Dieterich, A Chachoua, F Lafleur, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Cancer Treatment Reports|April 1, 1984
Activity of mitolactol in cancer of the uterine cervixV Lira-Puerto, F Morales-Canfield, J Wernz, et al.
The Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.
Acta Cytologica|July 1, 1977
A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspiratesF T Elequin, F M Muggia, N A Ghossein, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
BRCA1 germline mutation presenting as an adenocarcinoma of unknown primaryP Klein, G Prolla, R Wallach, et al.
Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomasA A Garcia, R A Kempf, M Rogers, et al.
Pageof 397